Feedback
  • Account Access
  • Contact Us
    '

    Pre-Sales Support

    Mutual Funds and ETFs - 800-456-7526
    Monday-Thursday: 8:00 a.m. – 6:00 p.m. ET
    Friday: 8:00 a.m. – 5:00 p.m. ET

    ETF Trading Support - 415-315-6600
    Monday-Friday: 9:30 a.m. – 5:00 p.m. ET

    Post-Sales and Website Support
    888-843-7824
    Monday-Friday: 9:00 a.m. - 6:00 p.m. ET

  • Advisor Log In

Hartford Healthcare HLS Fund

Explore Another ETFs

Objective

Seeks long-term growth of capital.

Overview

A stock fund that invests in health care, a sector that is experiencing innovations and breakthroughs across multiple subsectors.

Effective 12/31/17, this Fund is closed to certain qualified pension and retirement plans.  For more information, please refer to the fund's statutory prospectus.

More About Healthcare HLS Fund 

Performance

Performance (%)
% (as of 6/30/2018)
Average Annual Total Returns % (as of 6/30/2018)
YTD 1YR 3YR 5YR 10YR SI
Hartford Healthcare HLS  IA 5.65 5.76 5.10 16.23 13.76 12.32
Benchmark 3.28 8.60 6.49 14.38 13.20 ---
Morningstar Health Category 7.72 12.99 3.79 15.17 13.65 ---
Performance (%)
% (as of 6/30/2018)
Average Annual Total Returns % (as of 6/30/2018)
YTD 1YR 3YR 5YR 10YR SI
Hartford Healthcare HLS  IA 5.65 5.76 5.10 16.23 13.76 12.32
Benchmark 3.28 8.60 6.49 14.38 13.20 ---
Morningstar Health Category 7.72 12.99 3.79 15.17 13.65 ---
SI = Since Inception. Fund Inception: 05/01/2000
Operating Expenses:   Net  0.90% |  Gross  0.90%

Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted.

Prior to 4/1/2016, the Fund's benchmark was the S&P North American Health Care Sector Index.

Calendar Year Returns (%)
Fund Benchmark
2017 22.26 22.47
2016 -8.39 -2.05
2015 13.21 7.41
2014 27.39 24.79
2013 51.84 42.19
2012 20.62 18.35
2011 8.54 11.88
2010 7.10 5.20
2009 22.72 20.76
2008 -25.56 -23.76

Excludes sales charges. If sales charges and taxes had been included, the value would have been lower.

Characteristics Holdings are subject to change. Percentages may be rounded.

Statistics
As of Date 6/30/2018
Net Assets $329 million
# of Holdings 115
Beta 1.15
R Squared 0.89
% in Equities 97%
Turnover (3/31/2018) 22%
% in Foreign Equities 13%
Standard Deviation 15.90%
Holdings Characteristics
(as of 5/31/2018)
Fund S&P Composite 1500 Health Care Index
Asset Weighted Market Cap $48.3 billion $110.3 billion
EPS Growth Rate 17.7% 10.2%
Price/Book 4.3x 4.1x
Price/Earnings 39.0x 14.5x
Return on Equity -2.5% 21.8%

Subsector Exposure

(as of 5/31/2018)
label currentpercentage
Biopharma Mid Cap 21%
Biopharma Small Cap 13%
Medical Technology 26%
Health Care Services 23%
Biopharma Large Cap 16%
(as of 3/31/2018)
label currentpercentage
Biopharma Mid Cap 20%
Biopharma Small Cap 11%
Medical Technology 26%
Health Care Services 23%
Biopharma Large Cap 20%

Based on sub-adviser’s classification of health care subsectors, which includes combining biotechnology and pharmaceuticals in terms of capitalization: biopharma small-cap, biopharma mid-cap, and biopharma large-cap. Excludes cash. May not total to 100% due to rounding.

Top Holdings

(as of 5/31/2018)
label percentageholding
UnitedHealth Group, Inc. 6.04
Medtronic plc 4.37
Bristol-Myers Squibb Co. 3.54
Boston Scientific Corp. 2.97
Stryker Corp. 2.74
Allergan plc 2.72
Loxo Oncology, Inc. 2.68
Eli Lilly & Co. 2.45
Thermo Fisher Scientific, Inc. 2.40
AstraZeneca plc 2.32
Total Portfolio % 32.23
(as of 3/31/2018)
label percentageholding
UnitedHealth Group, Inc. 5.70
Medtronic plc 4.33
Bristol-Myers Squibb Co. 4.14
Allergan plc 3.23
Boston Scientific Corp. 2.82
Stryker Corp. 2.70
Thermo Fisher Scientific, Inc. 2.54
Eli Lilly & Co. 2.37
AstraZeneca plc 2.34
Abbott Laboratories 2.15
Total Portfolio % 32.32
Market Cap Distribution %
(as of 05/31/2018)
Less than $2 billion 16.3
$2 billion - $5 billion 8.3
$5 billion - $10 billion 16.1
Greater than $10 billion 59.4
Fund Essentials
Inception Date 05/01/2000
Symbol HIAHX
CUSIP 416528719
Fund Number 2055

Insights

pdf

The 5-Minute Forecast 3Q18 

Wed Jul 18 11:24:00 EDT 2018
A concise summary of the Hartford Funds Multi-Asset Team’s views on the main challenges facing investors: Growth, Income, Volatility, Inflation, and Taxes.
pdf

Client Conversations: HSAs: 1 Account, 3 Tax Benefits 

Thu Feb 15 12:00:00 EST 2018
Have a health savings account, but not contributing to it? You could be missing out.
pdf

2018 Outlooks (Schroders) 

Fri Dec 22 14:06:00 EST 2017
Thought leaders from Schroder Investment Management provide their outlook on issues that may influence markets and portfolios going forward.

Literature

Fund Literature

Select All

Expanded Commentary

03/31/2018 | pdf

Max 100

Summary Prospectus

05/01/2017 | pdf

Available For
Download Only

Semi Annual Report

06/30/2017 | pdf

Available For
Download Only

Statutory Prospectus

05/01/2017 | pdf

Available For
Download Only

Annual Report

12/31/2017 | pdf

Available For
Download Only

SAI

05/01/2017 | pdf

Available For
Download Only

Financial Professionals:

Log in to order forms and literature and manage your subscriptions.

A WORD ABOUT RISK

Investing involves risk, including the possible loss of principal. There is no guarantee a fund will achieve its stated objective. Security prices fluctuate in value depending on general market and economic conditions and the prospects of individual companies. Risks of focusing investments on the healthcare related sector include regulatory and legal developments, patent considerations, intense competitive pressures, rapid technological changes, potential product obsolescence, and liquidity risk. Foreign investments may be more volatile and less liquid than U.S. investments and are subject to the risk of currency fluctuations and adverse political and economic developments. These risks may be greater for investments in emerging markets. Small- and mid-cap securities can have greater risk and volatility than large-cap securities.
 

Hartford HLS Funds are distributed by Hartford Funds Distributors, LLC (HFD), Member FINRA. Advisory services are provided by Hartford Funds Management Company, LLC (HFMC). The Funds are sub-advised by Wellington Management Company LLP, which is not affiliated with HFD or HFMC.

206871